ReviewCurrent pathobiology reports2021

Chemokine-Based Therapeutics for the Treatment of Inflammatory and Fibrotic Convergent Pathways in COVID-19.

Dana R Julian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.